Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse
- 927 Downloads
The aims of the present study were to validate a measure of empowerment in a British population of people with a dual diagnosis of schizophrenia and substance misuse and assess relationships between empowerment and other key outcomes.
Patients participating in a large randomised control trial for Motivational Interviewing for Drug and Alcohol misuse in Schizophrenia or psychosis (MIDAS trial) completed measures of empowerment, symptoms, global functioning and substance use at baseline, 12- and 24-month follow-ups.
A three factor model of empowerment: self-efficacy and control; power and anger; and activism provided the best fit of the data across all three time points. There was some evidence of associations between empowerment and both symptoms and global functioning, although these associations were not consistent across subscales. Changes in empowerment predicted changes in symptoms and functioning at follow-up.
Empowerment is a broadly defined construct and its meaning may differ across different populations of people with severe and enduring mental health problems. Empowerment is a key component of recovery and should be assessed in treatments in addition to more traditional outcome measures of symptoms and functioning.
KeywordsEmpowerment Schizophrenia Substance misuse
We thank all participants who took part in the studies from the NHS Trusts and all the NHS staff who helped with recruitment. This research was supported by the Medical Research Council (MIDAS trial grant number—G0200471).
Conflict of interest
- 6.Es Rogers, Chamberlin J, Ellison ML, Crean TA (1992) Consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Ser 48:1042–1047Google Scholar
- 9.Maslin J (2003) Substance misuse in psychosis: contextual issues. In: Graham HL, Copella A, Birchwood MJ, Mueser KT (eds) Substance misuse in psychosis: approaches to treatment and service delivery. Wiley, UKGoogle Scholar
- 10.Weaver T, Rutter D, Maddon P, Ward J, Stimson G, Renton A (2001) Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 36:399–406PubMedCrossRefGoogle Scholar
- 12.Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N (2010) Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and co-morbid substance misuse: randomised controlled trial. BMJ 341:c6325PubMedCentralPubMedCrossRefGoogle Scholar
- 17.American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV), 4th edn. American Psychiatric Association, USAGoogle Scholar
- 24.Repper J, Perkins R (2003) Social inclusion and recovery. Bailliere Tindall, LondonGoogle Scholar
- 25.Miller WR, Rollinick S (2000) Motivational interviewing: preparing people for change, 2nd edn. Guilford Press, New YorkGoogle Scholar
- 27.Bejerholm U, Bjorkman T (2010) Empowerment in supported employment research and practice: is it relevant? Int J Soc Psychiatry 57:568–595Google Scholar